Publication Name	World Journal of Gastrointestinal Pathophysiology
Manuscript ID	29790
Country	United States

Received	2016-08-27 21:08
Peer-Review Started	2016-08-31 08:54
To Make the First Decision	2016-12-13 15:41
Return for Revision	2016-12-14 10:40
Revised	2016-12-30 09:38
Second Decision	2017-03-02 18:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-03-13 11:49
Articles in Press	2017-03-13 11:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-13 17:58
Publish the Manuscript Online	2017-05-16 06:56

ISSN	2150-5330 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Non-alcoholic fatty liver disease and cardiovascular risk
Manuscript Source	Invited Manuscript
All Author List	Rashmee Patil and Gagan K Sood
Funding Agency and Grant Number
Corresponding Author	Gagan K Sood, MD, Division of Gastroenterology and Hepatology, Baylor College of Medicine, St. Luke’s Liver Center, 6620 Main Street, Suite 1425, Baylor Clinic, Houston, TX 77030, United States. gksood@bcm.edu
Key Words	Non-alcoholic fatty liver disease; Cardio­vascular risk; Outcomes; Coronary artery disease; Steatosis
Core Tip	Non-alcoholic fatty liver disease (NAFLD) is often associated with insulin resistance and is strongly associated with type 2 diabetes mellitus and obesity. In addition to being at risk for nonalcoholic steatohepatitis, cirrhosis and its complications, NAFLD patients are also at higher risk of cardiovascular diseases (CVD), including coronary heart disease and stroke. NAFLD confers increased cardiovascular disease risk independent of traditional cardiovascular risk factors and metabolic syndrome. Close followup of patients with NAFLD may be indicated to prevent major vascular events. Risk stratification scores are needed that address both the risk for advanced liver disease and CVD.
Publish Date	2017-05-16 06:56
Citation	Patil R, Sood GK. Non-alcoholic fatty liver disease and cardiovascular risk. World J Gastrointest Pathophysiol 2017; 8(2): 51-58
URL	http://www.wjgnet.com/2150-5330/full/v8/i2/51.htm
DOI	http://dx.doi.org/10.4291/wjgp.v8.i2.51

Full Article (PDF)	WJGP-8-51.pdf
Full Article (Word)	WJGP-8-51.doc
Manuscript File	29790-Review.docx
Answering Reviewers	29790-Answering reivewers.pdf
Audio Core Tip	29790-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	29790-Conflict-of-interest statement.pdf
Copyright License Agreement	29790-Copyright assignment.pdf
Peer-review Report	29790-Peer-review(s).pdf
Scientific Misconduct Check	29790-Scientific misconduct check.pdf
Scientific Editor Work List	29790-Scientific editor work list.pdf